Hanmi becomes pharma having the highest No. of overseas new drug pipelines
It was observed Hanmi Pharm was the Korean pharmaceutical company which has the highest number of new drug pipelines in progress of overseas clinical trial.
According to the status of Korean pharmaceutical companies’ new drug pipelines, conducted by SK Securities, Hanmi Pharm is carrying out 6 n...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
